Global Needle-Free Drug Injection Systems Market Insights and Forecast to 2026


Needle-Free Drug Injection Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Needle-Free Drug Injection Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Needle-Free Drug Injection Systems market is segmented into
    Jet-Based Needle-Free Injectors
    Spring-Based Needle-Free Injectors
    Laser-Powered Needle-Free Injectors
    Vibration-Based Needle-Free Injectors

Segment by Application, the Needle-Free Drug Injection Systems market is segmented into
    Hospitals and Clinics
    Homecare Settings
    Research Laboratories
    Pharmaceutical and Biotechnology companies
    Other End Users

Regional and Country-level Analysis
The Needle-Free Drug Injection Systems market is analysed and market size information is provided by regions (countries).
The key regions covered in the Needle-Free Drug Injection Systems market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Needle-Free Drug Injection Systems Market Share Analysis

Needle-Free Drug Injection Systems market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Needle-Free Drug Injection Systems by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Needle-Free Drug Injection Systems business, the date to enter into the Needle-Free Drug Injection Systems market, Needle-Free Drug Injection Systems product introduction, recent developments, etc.
The major vendors covered:
    Antares Pharma, Inc. (US)
    Endo International plc (US)
    PharmaJet (U.S)
    Bioject Medical Technologies Inc. (U.S)
    Medical International Technology, Inc. (U.S)
    INJEX Pharma AG (Germany)
    National Medical Products Inc. (US)
    Valeritas, Inc. (US)
    European Pharma Group (Netherland)
    PenJet Corporation (U.S)
    Crossject SA (France)
1 Study Coverage
    1.1 Needle-Free Drug Injection Systems Product Introduction
    1.2 Key Market Segments in This Study
    1.3 Key Manufacturers Covered: Ranking of Global Top Needle-Free Drug Injection Systems Manufacturers by Revenue in 2019
    1.4 Market by Type
        1.4.1 Global Needle-Free Drug Injection Systems Market Size Growth Rate by Type
        1.4.2 Jet-Based Needle-Free Injectors
        1.4.3 Spring-Based Needle-Free Injectors
        1.4.4 Laser-Powered Needle-Free Injectors
        1.4.5 Vibration-Based Needle-Free Injectors
    1.5 Market by Application
        1.5.1 Global Needle-Free Drug Injection Systems Market Size Growth Rate by Application
        1.5.2 Hospitals and Clinics
        1.5.3 Homecare Settings
        1.5.4 Research Laboratories
        1.5.5 Pharmaceutical and Biotechnology companies
        1.5.6 Other End Users
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Needle-Free Drug Injection Systems Market Size, Estimates and Forecasts
        2.1.1 Global Needle-Free Drug Injection Systems Revenue Estimates and Forecasts 2015-2026
        2.1.2 Global Needle-Free Drug Injection Systems Production Capacity Estimates and Forecasts 2015-2026
        2.1.3 Global Needle-Free Drug Injection Systems Production Estimates and Forecasts 2015-2026
    2.2 Global Needle-Free Drug Injection Systems, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    2.3 Analysis of Competitive Landscape
        2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        2.3.2 Global Needle-Free Drug Injection Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
        2.3.3 Global Needle-Free Drug Injection Systems Manufacturers Geographical Distribution
    2.4 Key Trends for Needle-Free Drug Injection Systems Markets & Products
    2.5 Primary Interviews with Key Needle-Free Drug Injection Systems Players (Opinion Leaders)

3 Market Size by Manufacturers
    3.1 Global Top Needle-Free Drug Injection Systems Manufacturers by Production Capacity
        3.1.1 Global Top Needle-Free Drug Injection Systems Manufacturers by Production Capacity (2015-2020)
        3.1.2 Global Top Needle-Free Drug Injection Systems Manufacturers by Production (2015-2020)
        3.1.3 Global Top Needle-Free Drug Injection Systems Manufacturers Market Share by Production
    3.2 Global Top Needle-Free Drug Injection Systems Manufacturers by Revenue
        3.2.1 Global Top Needle-Free Drug Injection Systems Manufacturers by Revenue (2015-2020)
        3.2.2 Global Top Needle-Free Drug Injection Systems Manufacturers Market Share by Revenue (2015-2020)
        3.2.3 Global Top 10 and Top 5 Companies by Needle-Free Drug Injection Systems Revenue in 2019
    3.3 Global Needle-Free Drug Injection Systems Price by Manufacturers
    3.4 Mergers & Acquisitions, Expansion Plans

4 Needle-Free Drug Injection Systems Production by Regions
    4.1 Global Needle-Free Drug Injection Systems Historic Market Facts & Figures by Regions
        4.1.1 Global Top Needle-Free Drug Injection Systems Regions by Production (2015-2020)
        4.1.2 Global Top Needle-Free Drug Injection Systems Regions by Revenue (2015-2020)
    4.2 North America
        4.2.1 North America Needle-Free Drug Injection Systems Production (2015-2020)
        4.2.2 North America Needle-Free Drug Injection Systems Revenue (2015-2020)
        4.2.3 Key Players in North America
        4.2.4 North America Needle-Free Drug Injection Systems Import & Export (2015-2020)
    4.3 Europe
        4.3.1 Europe Needle-Free Drug Injection Systems Production (2015-2020)
        4.3.2 Europe Needle-Free Drug Injection Systems Revenue (2015-2020)
        4.3.3 Key Players in Europe
        4.3.4 Europe Needle-Free Drug Injection Systems Import & Export (2015-2020)
    4.4 China
        4.4.1 China Needle-Free Drug Injection Systems Production (2015-2020)
        4.4.2 China Needle-Free Drug Injection Systems Revenue (2015-2020)
        4.4.3 Key Players in China
        4.4.4 China Needle-Free Drug Injection Systems Import & Export (2015-2020)
    4.5 Japan
        4.5.1 Japan Needle-Free Drug Injection Systems Production (2015-2020)
        4.5.2 Japan Needle-Free Drug Injection Systems Revenue (2015-2020)
        4.5.3 Key Players in Japan
        4.5.4 Japan Needle-Free Drug Injection Systems Import & Export (2015-2020)

5 Needle-Free Drug Injection Systems Consumption by Region
    5.1 Global Top Needle-Free Drug Injection Systems Regions by Consumption
        5.1.1 Global Top Needle-Free Drug Injection Systems Regions by Consumption (2015-2020)
        5.1.2 Global Top Needle-Free Drug Injection Systems Regions Market Share by Consumption (2015-2020)
    5.2 North America
        5.2.1 North America Needle-Free Drug Injection Systems Consumption by Application
        5.2.2 North America Needle-Free Drug Injection Systems Consumption by Countries
        5.2.3 U.S.
        5.2.4 Canada
    5.3 Europe
        5.3.1 Europe Needle-Free Drug Injection Systems Consumption by Application
        5.3.2 Europe Needle-Free Drug Injection Systems Consumption by Countries
        5.3.3 Germany
        5.3.4 France
        5.3.5 U.K.
        5.3.6 Italy
        5.3.7 Russia
    5.4 Asia Pacific
        5.4.1 Asia Pacific Needle-Free Drug Injection Systems Consumption by Application
        5.4.2 Asia Pacific Needle-Free Drug Injection Systems Consumption by Regions
        5.4.3 China
        5.4.4 Japan
        5.4.5 South Korea
        5.4.6 India
        5.4.7 Australia
        5.4.8 Taiwan
        5.4.9 Indonesia
        5.4.10 Thailand
        5.4.11 Malaysia
        5.4.12 Philippines
        5.4.13 Vietnam
    5.5 Central & South America
        5.5.1 Central & South America Needle-Free Drug Injection Systems Consumption by Application
        5.5.2 Central & South America Needle-Free Drug Injection Systems Consumption by Country
        5.5.3 Mexico
        5.5.3 Brazil
        5.5.3 Argentina
    5.6 Middle East and Africa
        5.6.1 Middle East and Africa Needle-Free Drug Injection Systems Consumption by Application
        5.6.2 Middle East and Africa Needle-Free Drug Injection Systems Consumption by Countries
        5.6.3 Turkey
        5.6.4 Saudi Arabia
        5.6.5 U.A.E

6 Market Size by Type (2015-2026)
    6.1 Global Needle-Free Drug Injection Systems Market Size by Type (2015-2020)
        6.1.1 Global Needle-Free Drug Injection Systems Production by Type (2015-2020)
        6.1.2 Global Needle-Free Drug Injection Systems Revenue by Type (2015-2020)
        6.1.3 Needle-Free Drug Injection Systems Price by Type (2015-2020)
    6.2 Global Needle-Free Drug Injection Systems Market Forecast by Type (2021-2026)
        6.2.1 Global Needle-Free Drug Injection Systems Production Forecast by Type (2021-2026)
        6.2.2 Global Needle-Free Drug Injection Systems Revenue Forecast by Type (2021-2026)
        6.2.3 Global Needle-Free Drug Injection Systems Price Forecast by Type (2021-2026)
    6.3 Global Needle-Free Drug Injection Systems Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)
        7.2.1 Global Needle-Free Drug Injection Systems Consumption Historic Breakdown by Application (2015-2020)
        7.2.2 Global Needle-Free Drug Injection Systems Consumption Forecast by Application (2021-2026)

8 Corporate Profiles
    8.1 Antares Pharma, Inc. (US)
        8.1.1 Antares Pharma, Inc. (US) Corporation Information
        8.1.2 Antares Pharma, Inc. (US) Overview
        8.1.3 Antares Pharma, Inc. (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
        8.1.4 Antares Pharma, Inc. (US) Product Description
        8.1.5 Antares Pharma, Inc. (US) Related Developments
    8.2 Endo International plc (US)
        8.2.1 Endo International plc (US) Corporation Information
        8.2.2 Endo International plc (US) Overview
        8.2.3 Endo International plc (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
        8.2.4 Endo International plc (US) Product Description
        8.2.5 Endo International plc (US) Related Developments
    8.3 PharmaJet (U.S)
        8.3.1 PharmaJet (U.S) Corporation Information
        8.3.2 PharmaJet (U.S) Overview
        8.3.3 PharmaJet (U.S) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
        8.3.4 PharmaJet (U.S) Product Description
        8.3.5 PharmaJet (U.S) Related Developments
    8.4 Bioject Medical Technologies Inc. (U.S)
        8.4.1 Bioject Medical Technologies Inc. (U.S) Corporation Information
        8.4.2 Bioject Medical Technologies Inc. (U.S) Overview
        8.4.3 Bioject Medical Technologies Inc. (U.S) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
        8.4.4 Bioject Medical Technologies Inc. (U.S) Product Description
        8.4.5 Bioject Medical Technologies Inc. (U.S) Related Developments
    8.5 Medical International Technology, Inc. (U.S)
        8.5.1 Medical International Technology, Inc. (U.S) Corporation Information
        8.5.2 Medical International Technology, Inc. (U.S) Overview
        8.5.3 Medical International Technology, Inc. (U.S) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
        8.5.4 Medical International Technology, Inc. (U.S) Product Description
        8.5.5 Medical International Technology, Inc. (U.S) Related Developments
    8.6 INJEX Pharma AG (Germany)
        8.6.1 INJEX Pharma AG (Germany) Corporation Information
        8.6.2 INJEX Pharma AG (Germany) Overview
        8.6.3 INJEX Pharma AG (Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
        8.6.4 INJEX Pharma AG (Germany) Product Description
        8.6.5 INJEX Pharma AG (Germany) Related Developments
    8.7 National Medical Products Inc. (US)
        8.7.1 National Medical Products Inc. (US) Corporation Information
        8.7.2 National Medical Products Inc. (US) Overview
        8.7.3 National Medical Products Inc. (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
        8.7.4 National Medical Products Inc. (US) Product Description
        8.7.5 National Medical Products Inc. (US) Related Developments
    8.8 Valeritas, Inc. (US)
        8.8.1 Valeritas, Inc. (US) Corporation Information
        8.8.2 Valeritas, Inc. (US) Overview
        8.8.3 Valeritas, Inc. (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
        8.8.4 Valeritas, Inc. (US) Product Description
        8.8.5 Valeritas, Inc. (US) Related Developments
    8.9 European Pharma Group (Netherland)
        8.9.1 European Pharma Group (Netherland) Corporation Information
        8.9.2 European Pharma Group (Netherland) Overview
        8.9.3 European Pharma Group (Netherland) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
        8.9.4 European Pharma Group (Netherland) Product Description
        8.9.5 European Pharma Group (Netherland) Related Developments
    8.10 PenJet Corporation (U.S)
        8.10.1 PenJet Corporation (U.S) Corporation Information
        8.10.2 PenJet Corporation (U.S) Overview
        8.10.3 PenJet Corporation (U.S) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
        8.10.4 PenJet Corporation (U.S) Product Description
        8.10.5 PenJet Corporation (U.S) Related Developments
    8.11 Crossject SA (France)
        8.11.1 Crossject SA (France) Corporation Information
        8.11.2 Crossject SA (France) Overview
        8.11.3 Crossject SA (France) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
        8.11.4 Crossject SA (France) Product Description
        8.11.5 Crossject SA (France) Related Developments

9 Needle-Free Drug Injection Systems Production Forecast by Regions
    9.1 Global Top Needle-Free Drug Injection Systems Regions Forecast by Revenue (2021-2026)
    9.2 Global Top Needle-Free Drug Injection Systems Regions Forecast by Production (2021-2026)
    9.3 Key Needle-Free Drug Injection Systems Production Regions Forecast
        9.3.1 North America
        9.3.2 Europe
        9.3.3 China
        9.3.4 Japan

10 Needle-Free Drug Injection Systems Consumption Forecast by Region
    10.1 Global Needle-Free Drug Injection Systems Consumption Forecast by Region (2021-2026)
    10.2 North America Needle-Free Drug Injection Systems Consumption Forecast by Region (2021-2026)
    10.3 Europe Needle-Free Drug Injection Systems Consumption Forecast by Region (2021-2026)
    10.4 Asia Pacific Needle-Free Drug Injection Systems Consumption Forecast by Region (2021-2026)
    10.5 Latin America Needle-Free Drug Injection Systems Consumption Forecast by Region (2021-2026)
    10.6 Middle East and Africa Needle-Free Drug Injection Systems Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis
    11.1 Value Chain Analysis
    11.2 Sales Channels Analysis
        11.2.1 Needle-Free Drug Injection Systems Sales Channels
        11.2.2 Needle-Free Drug Injection Systems Distributors
    11.3 Needle-Free Drug Injection Systems Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
    12.1 Needle-Free Drug Injection Systems Industry
    12.2 Market Trends
    12.3 Market Opportunities and Drivers
    12.4 Market Challenges
    12.5 Needle-Free Drug Injection Systems Market Risks/Restraints
    12.6 Porter's Five Forces Analysis
13 Key Finding in The Global Needle-Free Drug Injection Systems Study
14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

List of Tables Table 1. Needle-Free Drug Injection Systems Key Market Segments in This Study Table 2. Ranking of Global Top Needle-Free Drug Injection Systems Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Needle-Free Drug Injection Systems Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$) Table 4. Major Manufacturers of Jet-Based Needle-Free Injectors Table 5. Major Manufacturers of Spring-Based Needle-Free Injectors Table 6. Major Manufacturers of Laser-Powered Needle-Free Injectors Table 7. Major Manufacturers of Vibration-Based Needle-Free Injectors Table 8. Global Needle-Free Drug Injection Systems Market Size Growth Rate by Application 2020-2026 (K Units) Table 9. Global Needle-Free Drug Injection Systems Market Size by Region in US$ Million: 2015 VS 2020 VS 2026 Table 10. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 11. Global Needle-Free Drug Injection Systems by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Needle-Free Drug Injection Systems as of 2019) Table 12. Needle-Free Drug Injection Systems Manufacturing Base Distribution and Headquarters Table 13. Manufacturers Needle-Free Drug Injection Systems Product Offered Table 14. Date of Manufacturers Enter into Needle-Free Drug Injection Systems Market Table 15. Key Trends for Needle-Free Drug Injection Systems Markets & Products Table 16. Main Points Interviewed from Key Needle-Free Drug Injection Systems Players Table 17. Global Needle-Free Drug Injection Systems Production Capacity by Manufacturers (2015-2020) (K Units) Table 18. Global Needle-Free Drug Injection Systems Production Share by Manufacturers (2015-2020) Table 19. Needle-Free Drug Injection Systems Revenue by Manufacturers (2015-2020) (Million US$) Table 20. Needle-Free Drug Injection Systems Revenue Share by Manufacturers (2015-2020) Table 21. Needle-Free Drug Injection Systems Price by Manufacturers 2015-2020 (USD/Unit) Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Needle-Free Drug Injection Systems Production by Regions (2015-2020) (K Units) Table 24. Global Needle-Free Drug Injection Systems Production Market Share by Regions (2015-2020) Table 25. Global Needle-Free Drug Injection Systems Revenue by Regions (2015-2020) (US$ Million) Table 26. Global Needle-Free Drug Injection Systems Revenue Market Share by Regions (2015-2020) Table 27. Key Needle-Free Drug Injection Systems Players in North America Table 28. Import & Export of Needle-Free Drug Injection Systems in North America (K Units) Table 29. Key Needle-Free Drug Injection Systems Players in Europe Table 30. Import & Export of Needle-Free Drug Injection Systems in Europe (K Units) Table 31. Key Needle-Free Drug Injection Systems Players in China Table 32. Import & Export of Needle-Free Drug Injection Systems in China (K Units) Table 33. Key Needle-Free Drug Injection Systems Players in Japan Table 34. Import & Export of Needle-Free Drug Injection Systems in Japan (K Units) Table 35. Global Needle-Free Drug Injection Systems Consumption by Regions (2015-2020) (K Units) Table 36. Global Needle-Free Drug Injection Systems Consumption Market Share by Regions (2015-2020) Table 37. North America Needle-Free Drug Injection Systems Consumption by Application (2015-2020) (K Units) Table 38. North America Needle-Free Drug Injection Systems Consumption by Countries (2015-2020) (K Units) Table 39. Europe Needle-Free Drug Injection Systems Consumption by Application (2015-2020) (K Units) Table 40. Europe Needle-Free Drug Injection Systems Consumption by Countries (2015-2020) (K Units) Table 41. Asia Pacific Needle-Free Drug Injection Systems Consumption by Application (2015-2020) (K Units) Table 42. Asia Pacific Needle-Free Drug Injection Systems Consumption Market Share by Application (2015-2020) (K Units) Table 43. Asia Pacific Needle-Free Drug Injection Systems Consumption by Regions (2015-2020) (K Units) Table 44. Latin America Needle-Free Drug Injection Systems Consumption by Application (2015-2020) (K Units) Table 45. Latin America Needle-Free Drug Injection Systems Consumption by Countries (2015-2020) (K Units) Table 46. Middle East and Africa Needle-Free Drug Injection Systems Consumption by Application (2015-2020) (K Units) Table 47. Middle East and Africa Needle-Free Drug Injection Systems Consumption by Countries (2015-2020) (K Units) Table 48. Global Needle-Free Drug Injection Systems Production by Type (2015-2020) (K Units) Table 49. Global Needle-Free Drug Injection Systems Production Share by Type (2015-2020) Table 50. Global Needle-Free Drug Injection Systems Revenue by Type (2015-2020) (Million US$) Table 51. Global Needle-Free Drug Injection Systems Revenue Share by Type (2015-2020) Table 52. Needle-Free Drug Injection Systems Price by Type 2015-2020 (USD/Unit) Table 53. Global Needle-Free Drug Injection Systems Consumption by Application (2015-2020) (K Units) Table 54. Global Needle-Free Drug Injection Systems Consumption Share by Application (2015-2020) Table 55. Antares Pharma, Inc. (US) Corporation Information Table 56. Antares Pharma, Inc. (US) Description and Major Businesses Table 57. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 58. Antares Pharma, Inc. (US) Product Table 59. Antares Pharma, Inc. (US) Recent Development Table 60. Endo International plc (US) Corporation Information Table 61. Endo International plc (US) Description and Major Businesses Table 62. Endo International plc (US) Needle-Free Drug Injection Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 63. Endo International plc (US) Product Table 64. Endo International plc (US) Recent Development Table 65. PharmaJet (U.S) Corporation Information Table 66. PharmaJet (U.S) Description and Major Businesses Table 67. PharmaJet (U.S) Needle-Free Drug Injection Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 68. PharmaJet (U.S) Product Table 69. PharmaJet (U.S) Recent Development Table 70. Bioject Medical Technologies Inc. (U.S) Corporation Information Table 71. Bioject Medical Technologies Inc. (U.S) Description and Major Businesses Table 72. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 73. Bioject Medical Technologies Inc. (U.S) Product Table 74. Bioject Medical Technologies Inc. (U.S) Recent Development Table 75. Medical International Technology, Inc. (U.S) Corporation Information Table 76. Medical International Technology, Inc. (U.S) Description and Major Businesses Table 77. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 78. Medical International Technology, Inc. (U.S) Product Table 79. Medical International Technology, Inc. (U.S) Recent Development Table 80. INJEX Pharma AG (Germany) Corporation Information Table 81. INJEX Pharma AG (Germany) Description and Major Businesses Table 82. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 83. INJEX Pharma AG (Germany) Product Table 84. INJEX Pharma AG (Germany) Recent Development Table 85. National Medical Products Inc. (US) Corporation Information Table 86. National Medical Products Inc. (US) Description and Major Businesses Table 87. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 88. National Medical Products Inc. (US) Product Table 89. National Medical Products Inc. (US) Recent Development Table 90. Valeritas, Inc. (US) Corporation Information Table 91. Valeritas, Inc. (US) Description and Major Businesses Table 92. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 93. Valeritas, Inc. (US) Product Table 94. Valeritas, Inc. (US) Recent Development Table 95. European Pharma Group (Netherland) Corporation Information Table 96. European Pharma Group (Netherland) Description and Major Businesses Table 97. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 98. European Pharma Group (Netherland) Product Table 99. European Pharma Group (Netherland) Recent Development Table 100. PenJet Corporation (U.S) Corporation Information Table 101. PenJet Corporation (U.S) Description and Major Businesses Table 102. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 103. PenJet Corporation (U.S) Product Table 104. PenJet Corporation (U.S) Recent Development Table 105. Crossject SA (France) Corporation Information Table 106. Crossject SA (France) Description and Major Businesses Table 107. Crossject SA (France) Needle-Free Drug Injection Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 108. Crossject SA (France) Product Table 109. Crossject SA (France) Recent Development Table 110. Global Needle-Free Drug Injection Systems Revenue Forecast by Region (2021-2026) (Million US$) Table 111. Global Needle-Free Drug Injection Systems Production Forecast by Regions (2021-2026) (K Units) Table 112. Global Needle-Free Drug Injection Systems Production Forecast by Type (2021-2026) (K Units) Table 113. Global Needle-Free Drug Injection Systems Revenue Forecast by Type (2021-2026) (Million US$) Table 114. North America Needle-Free Drug Injection Systems Consumption Forecast by Regions (2021-2026) (K Units) Table 115. Europe Needle-Free Drug Injection Systems Consumption Forecast by Regions (2021-2026) (K Units) Table 116. Asia Pacific Needle-Free Drug Injection Systems Consumption Forecast by Regions (2021-2026) (K Units) Table 117. Latin America Needle-Free Drug Injection Systems Consumption Forecast by Regions (2021-2026) (K Units) Table 118. Middle East and Africa Needle-Free Drug Injection Systems Consumption Forecast by Regions (2021-2026) (K Units) Table 119. Needle-Free Drug Injection Systems Distributors List Table 120. Needle-Free Drug Injection Systems Customers List Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 122. Key Challenges Table 123. Market Risks Table 124. Research Programs/Design for This Report Table 125. Key Data Information from Secondary Sources Table 126. Key Data Information from Primary Sources List of Fifures Figure 1. Needle-Free Drug Injection Systems Product Picture Figure 2. Global Needle-Free Drug Injection Systems Production Market Share by Type in 2020 & 2026 Figure 3. Jet-Based Needle-Free Injectors Product Picture Figure 4. Spring-Based Needle-Free Injectors Product Picture Figure 5. Laser-Powered Needle-Free Injectors Product Picture Figure 6. Vibration-Based Needle-Free Injectors Product Picture Figure 7. Global Needle-Free Drug Injection Systems Consumption Market Share by Application in 2020 & 2026 Figure 8. Hospitals and Clinics Figure 9. Homecare Settings Figure 10. Research Laboratories Figure 11. Pharmaceutical and Biotechnology companies Figure 12. Other End Users Figure 13. Needle-Free Drug Injection Systems Report Years Considered Figure 14. Global Needle-Free Drug Injection Systems Revenue 2015-2026 (Million US$) Figure 15. Global Needle-Free Drug Injection Systems Production Capacity 2015-2026 (K Units) Figure 16. Global Needle-Free Drug Injection Systems Production 2015-2026 (K Units) Figure 17. Global Needle-Free Drug Injection Systems Market Share Scenario by Region in Percentage: 2020 Versus 2026 Figure 18. Needle-Free Drug Injection Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Needle-Free Drug Injection Systems Production Share by Manufacturers in 2015 Figure 20. The Top 10 and Top 5 Players Market Share by Needle-Free Drug Injection Systems Revenue in 2019 Figure 21. Global Needle-Free Drug Injection Systems Production Market Share by Region (2015-2020) Figure 22. Needle-Free Drug Injection Systems Production Growth Rate in North America (2015-2020) (K Units) Figure 23. Needle-Free Drug Injection Systems Revenue Growth Rate in North America (2015-2020) (US$ Million) Figure 24. Needle-Free Drug Injection Systems Production Growth Rate in Europe (2015-2020) (K Units) Figure 25. Needle-Free Drug Injection Systems Revenue Growth Rate in Europe (2015-2020) (US$ Million) Figure 26. Needle-Free Drug Injection Systems Production Growth Rate in China (2015-2020) (K Units) Figure 27. Needle-Free Drug Injection Systems Revenue Growth Rate in China (2015-2020) (US$ Million) Figure 28. Needle-Free Drug Injection Systems Production Growth Rate in Japan (2015-2020) (K Units) Figure 29. Needle-Free Drug Injection Systems Revenue Growth Rate in Japan (2015-2020) (US$ Million) Figure 30. Global Needle-Free Drug Injection Systems Consumption Market Share by Regions 2015-2020 Figure 31. North America Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 32. North America Needle-Free Drug Injection Systems Consumption Market Share by Application in 2019 Figure 33. North America Needle-Free Drug Injection Systems Consumption Market Share by Countries in 2019 Figure 34. U.S. Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 35. Canada Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 36. Europe Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 37. Europe Needle-Free Drug Injection Systems Consumption Market Share by Application in 2019 Figure 38. Europe Needle-Free Drug Injection Systems Consumption Market Share by Countries in 2019 Figure 39. Germany Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 40. France Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 41. U.K. Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 42. Italy Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 43. Russia Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 44. Asia Pacific Needle-Free Drug Injection Systems Consumption and Growth Rate (K Units) Figure 45. Asia Pacific Needle-Free Drug Injection Systems Consumption Market Share by Application in 2019 Figure 46. Asia Pacific Needle-Free Drug Injection Systems Consumption Market Share by Regions in 2019 Figure 47. China Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 48. Japan Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 49. South Korea Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 50. India Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 51. Australia Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 52. Taiwan Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 53. Indonesia Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 54. Thailand Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 55. Malaysia Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 56. Philippines Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 57. Vietnam Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 58. Latin America Needle-Free Drug Injection Systems Consumption and Growth Rate (K Units) Figure 59. Latin America Needle-Free Drug Injection Systems Consumption Market Share by Application in 2019 Figure 60. Latin America Needle-Free Drug Injection Systems Consumption Market Share by Countries in 2019 Figure 61. Mexico Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 62. Brazil Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 63. Argentina Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 64. Middle East and Africa Needle-Free Drug Injection Systems Consumption and Growth Rate (K Units) Figure 65. Middle East and Africa Needle-Free Drug Injection Systems Consumption Market Share by Application in 2019 Figure 66. Middle East and Africa Needle-Free Drug Injection Systems Consumption Market Share by Countries in 2019 Figure 67. Turkey Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 68. Saudi Arabia Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 69. U.A.E Needle-Free Drug Injection Systems Consumption and Growth Rate (2015-2020) (K Units) Figure 70. Global Needle-Free Drug Injection Systems Production Market Share by Type (2015-2020) Figure 71. Global Needle-Free Drug Injection Systems Production Market Share by Type in 2019 Figure 72. Global Needle-Free Drug Injection Systems Revenue Market Share by Type (2015-2020) Figure 73. Global Needle-Free Drug Injection Systems Revenue Market Share by Type in 2019 Figure 74. Global Needle-Free Drug Injection Systems Production Market Share Forecast by Type (2021-2026) Figure 75. Global Needle-Free Drug Injection Systems Revenue Market Share Forecast by Type (2021-2026) Figure 76. Global Needle-Free Drug Injection Systems Market Share by Price Range (2015-2020) Figure 77. Global Needle-Free Drug Injection Systems Consumption Market Share by Application (2015-2020) Figure 78. Global Needle-Free Drug Injection Systems Value (Consumption) Market Share by Application (2015-2020) Figure 79. Global Needle-Free Drug Injection Systems Consumption Market Share Forecast by Application (2021-2026) Figure 80. Global Needle-Free Drug Injection Systems Revenue Forecast by Regions (2021-2026) (US$ Million) Figure 81. Global Needle-Free Drug Injection Systems Revenue Market Share Forecast by Regions ((2021-2026)) Figure 82. Global Needle-Free Drug Injection Systems Production Forecast by Regions (2021-2026) (K Units) Figure 83. North America Needle-Free Drug Injection Systems Production Forecast (2021-2026) (K Units) Figure 84. North America Needle-Free Drug Injection Systems Revenue Forecast (2021-2026) (US$ Million) Figure 85. Europe Needle-Free Drug Injection Systems Production Forecast (2021-2026) (K Units) Figure 86. Europe Needle-Free Drug Injection Systems Revenue Forecast (2021-2026) (US$ Million) Figure 87. China Needle-Free Drug Injection Systems Production Forecast (2021-2026) (K Units) Figure 88. China Needle-Free Drug Injection Systems Revenue Forecast (2021-2026) (US$ Million) Figure 89. Japan Needle-Free Drug Injection Systems Production Forecast (2021-2026) (K Units) Figure 90. Japan Needle-Free Drug Injection Systems Revenue Forecast (2021-2026) (US$ Million) Figure 91. Global Needle-Free Drug Injection Systems Consumption Market Share Forecast by Region (2021-2026) Figure 92. Needle-Free Drug Injection Systems Value Chain Figure 93. Channels of Distribution Figure 94. Distributors Profiles Figure 95. Porter's Five Forces Analysis Figure 96. Bottom-up and Top-down Approaches for This Report Figure 97. Data Triangulation Figure 98. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Medical Devices Reports

Portable Dialysis Devices Market Size, Share | Industry Analysis Report, 2026

According to credible estimates, the global portable dialysis devices market is expected to register substantial growth by the year 2026. Advancements in computer, miniaturization, and nanotechnology along with growing inclination towards portable me...

SPECT & SPECT-CT Market | Industry Analysis, Trends, and Forecast to 2025

SPECT and SPECT-CT market is likely to witness lucrative gains over 2020-2025 and reach a valuation of US $1810.9 million by the end of the forecast period. According to the estimates by reliable sources, the global SPECT and SPECT-CT market is anti...

Global Medical Bone Densitometers Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Market Overview The global Medical Bone Densitometers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, ...

Global Fatigue Tester Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Market Overview The global Fatigue Tester market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx ...

Global Examination Camera Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Market Overview The global Examination Camera market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD...

Other Reports by QY Research

Global Real-time Production Monitoring Software Market Size, Status and Forecast 2020-2026

Real-time Production Monitoring Software market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Real-time Production Monitoring Software market will be able to gain the upper hand as they use the ...

Global Automotive Acoustic Insulation Materials Market Insights and Forecast to 2026

Automotive Acoustic Insulation Materials market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Automotive Acoustic Insulation Materials market will be able to gain the upper hand as they use the ...

Global Kvass Market Insights and Forecast to 2026

Kvass market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Kvass market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales...

Global Trailer Tire Inflation Systems Market Insights and Forecast to 2026

Trailer Tire Inflation Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Trailer Tire Inflation Systems market will be able to gain the upper hand as they use the report as a powerful...

Global Lipgloss Market Insights and Forecast to 2026

Lipgloss market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lipgloss market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on...

Publisher: QY Research
Chat with us